KRAS and colorectal carcinoma: This study aims to examine the immunohistochemical expression pattern of both P4HA2 and SLUG in CRC specimens, then to assess their relation to different clinicopathological features including KRAS mutations and patients’ survival, and finally to study the correlation between both proteins in CRC.